RMRichard Simon Machado

Richard Simon Machado

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Richard Simon Machado has a total of 72 co-authors. Here are the top co-authors by number of shared publications:

  • Fabricia Petronilho

    Laboratory of Experimental Neurology, Graduate Program in Health Sciences, University of Southern Santa Catarina (UNESC), Criciúma, Brazil

    6 shared publications
  • Lucineia Gainski Danielski

    Department of Surgery, Division of Surgical Sciences, University of Texas Medical Branch, Galveston, TX, USA

    3 shared publications
  • Eduardo de Medeiros Peretti

    Laboratory of Neurobiology of Inflammatory and Metabolic Processes, Graduate Program in Health Sciences, Health Sciences Unit University of Southern Santa Catarina (UNISUL) Tubarão Brazil

    2 shared publications
  • Fabiana Durante de Medeiros

    Laboratory of Neurobiology of Inflammatory and Metabolic Processes, Graduate Program in Health Sciences, Health Sciences Unit University of Southern Santa Catarina (UNISUL) Tubarão Brazil

    2 shared publications
  • Juliana de Oliveira

    Laboratory of Neurobiology of Inflammatory and Metabolic Processes, Graduate Program in Health Sciences, Health Sciences Unit University of Southern Santa Catarina (UNISUL) Tubarão Brazil

    2 shared publications
  • Kiuanne Lino Lobo Metzker

    Health Sciences Unit, Laboratory of Neurobiology of Inflammatory and Metabolic Processes, Graduate Program in Health Sciences, University of South Santa Catarina, Tubarao, Brazil

    2 shared publications

Latest Publications

  • The Endocannabinoid System as a Target for Ischemic Stroke Therapy

    by Solange de Souza Stork, Khiany Mathias, David dos Santos, Fabrício Weinheimer Lippert, Richard Simon Machado, Victor Duílio Maragno, Larissa Joaquim, Samara Souza Stork, Rafael Mariano Bitencourt, Franciane Bobinski, et al.

    Introduction: Cannabinoids are increasingly being explored as a potential treatment for neurodegenerative diseases. This article aims to provide a narrative review of available data on the treatment of neurological disorders with cannabis constituents, focusing on ischemic stroke. Methods: Selected articles are summarized to describe design, results, limitations, conclusions, and implications about this theme. Results: The growing understanding of the endocannabinoid system and the cannabinoid receptors distribution in all human body systems and organs and particularly in brain structures importantly involved in myelination processes, suggests potential benefits for stroke symptoms and overall patient improvement. However, the variety of studied compounds, the different administration routes, dosages, and timing complicates data comparison, especially due to limited studies about these compounds, peculiarly in stroke patients. Thereat, this review to showcase disparities in findings and to summarize current advancements in cannabinoid use for potential future treatments. Conclusion: This article offers a review of the current literature in the field and discuss a pragmatic approach to the clinical use of cannabinoids in patients with ischemic stroke.


  • Open Access

    Early Impact of Bariatric Surgery on Brain Functionality

    by Bruna Barros Fernandes, Larissa Espindola da Silva, Stefanny da Silva Willemann, Mariella Reinol Steiner, Mariana Pacheco de Oliveira, Richard Simon Machado, Francisco J Cidral-Filho, Patrick Porter, Daniel Fernandes Martins, Gislaine Tezza Rezin

    Fernandes BB, et al. J Metab Bariatr Surg. 2025 Aug;14(2):106-123. https://doi.org/10.17476/jmbs.2025.14.2.106

  • Open Access

    Multiple Malformations of the Craniocervical Junction in German Spitz Adult Dog

    by Emerson Gonçalves Martins Siqueira, Richard Simon Machado, Ivan Felismino Charas dos Santos, Rogério Martins Amorim, Carolina Hagy Girotto, Raquel Azevedo dos Santos Madi, Vinicius dos Santos Rosa, Evelyn Rabelo Andrade

    Background: Craniocervical junction abnormalities (CJA) are described as complex congenital malformations affecting the caudal occipital region and 1st cervical vertebrae. These abnormalities often include Chiari malformations, atlanto-occipital overlapping, cervical canal stenosis, and atlantoaxial instability. There are few descriptions of these conditions in veterinary literature, despite their relevance. This report’s aim is to describe a case of complex craniocervical malformation in a dog, presenting the clinical findings, diagnostic methods, surgical treatment, and post-operative evolution, thus improving the understanding and management of such cases in veterinary practice. Case: A 4-year-old German Spitz dog, weighing 4.6 kg, was presented to a Veterinary Hospital in São Paulo State with a history of cervical hyperesthesia and non-ambulatory tetraparesis. Neurological examination revealed an absence of conscious proprioception in both thoracic and pelvic limbs, along with segmental hyperreflexia, pointing the neurolocalization of the lesion to the C1-C5 spinal segment. The dog's clinical evolution indicated further involvement of the brainstem, thalamic, and cerebellar regions. Cervical radiographs showed changes suggestive of craniocervical and vertebral malformations at C1-C2. Magnetic resonance imaging (MRI) further elucidated these findings, revealing a complex malformation causing significant compression of the medulla oblongata, atlanto-occipital overlapping, dysplasia/hypoplasia of the occipital bone, and mild cerebellar herniation, leading to partial obstruction of cerebrospinal fluid (CSF) flow. CSF cytology did not show significant abnormalities. Due to the unfavorable evolution of the patient, it was necessary to intervene surgically. The dog underwent foramen magnum decompression (FMD) with suboccipital craniectomy associated to cranioplasty using titanium mesh. Additionally, C1 laminoplasty and C1-C2 laminectomy were performed to maintain the stability of the atlanto-occipital joint and provide access to the dura mater. The dog presented a gradual and complete recovery of its motor function in the post-operative period, indicating a successful surgical treatment. Discussion: This case highlights the importance of advanced diagnostic imaging, such as MRI, in accurately identifying and assessing craniocervical junction abnormalities in dogs beyond what radiographs are able to identify. The successful surgical outcome obtained in this case shows the effectiveness of combining different surgical approaches for the management of such malformations. The foramen magnum decompression with cranioplasty, C1 laminoplasty, and C1-C2 laminectomy are great examples of fruitful combined techniques. Conservative therapies, such as pain management and the use of carbonic anhydrase inhibitors, may be satisfactory treatment options but could be insufficient for severe cases. Surgical intervention, as demonstrated, can significantly improve prognosis and quality of life by relieving compressive forces on the medulla oblongata and restoring normal CSF flow. The use of cranioplasty is particularly beneficial in reducing complications associated with scar tissue formation. This report adds valuable data to the limited veterinary literature on CJA, emphasizing the need for precise diagnosis and the advantages of the association of surgical approaches. This knowledge will ultimately improve treatment outcomes and the quality of life for animals with such abnormalities. Keywords: laminectomy, malformation, magnetic resonance, small animals, surgery.

  • Oxidative stress and mitochondrial dysfunction contributes to postoperative cognitive dysfunction in elderly rats dependent on NLRP3 activation

    by Sandra Bonfante, Martins Back Netto, Aloir Neri de Oliveira Junior, Khiany Mathias, Richard Simon Machado, Larissa Joaquim, Taina Cidreira, Marina Goulart da Silva, Guilherme Cabreira Daros, Lucinéia Gainski Danielski, et al.

    Postoperative cognitive dysfunction (POCD), a complication following procedures such as orthopedic surgery, is associated with a worsened prognosis, especially in the elderly population. Several mechanisms have been proposed for communication between the immune system and the brain after surgery. In an experimental tibial fracture (TF) model, we aimed to understand the role of the NLR family pyrin domain containing 3 (NLRP3) on oxidative stress and mitochondrial dysfunction as mechanisms underlying POCD in aged and adult rats. Adult or aged male Wistar rats were subjected to the TF model and received intracerebroventricular saline or MCC950 (140 ng/kg), a specific small-molecule inhibitor that selectively blocks activation of the NLRP3 inflammasome. We followed the control (sham) and TF groups treated with MCC950 or saline for seven days to determine cognitive function and survival. The prefrontal cortex and hippocampus were isolated for NLRP3 evaluation, cytokine analysis, oxidative stress measurements, myeloperoxidase activity, nitric oxide formation, mitochondrial respiratory chain enzymes, and succinate dehydrogenase (SDH) activity. Seven days after TF induction, NLRP3 levels increased in the hippocampus and prefrontal cortex in both ages, showed an enhancement in aged rats compared to adults, and experienced a reversal with MCC950 administration. The administration of MCC950 restored memory, IL-1β and IL-10 levels, nitrite/nitrate, lipid peroxidation in the hippocampus and prefrontal cortex, and preserved catalase activity in the prefrontal cortex in aged rats. At the same age, the complex I activity alteration in both regions and complex II, IV, and SDH in the prefrontal cortex were reversed. In conclusion, NLRP3 activation contributes to POCD development because it is intrinsically involved in mitochondrial dysfunction and oxidative stress after orthopedic surgery in aged rats.


  • The Infected Lungs and Brain Interface in COVID-19: The Impact on Cognitive Function

    by Larissa Joaquim, Amanda Della Giustina, Richard Simon Machado, Kiuanne Lino Lobo Metzker, Sandra Bonfante, Lucineia Gainski Danielski, Mariana Pereira de Souza Goldim, Fabricia Petronilho

    Many coronavirus disease 2019 (COVID-19)-recovered patients report signs and symptoms and are experiencing neurological, psychiatric, and cognitive problems. However, the exact prevalence and outcome of cognitive sequelae is unclear. Even though the severe acute respiratory syndrome coronavirus 2 has target brain cells through binding to angiotensin-converting enzyme 2 (ACE2) receptor in acute infection, several studies indicate the absence of the virus in the brain of many COVID-19 patients who developed neurological disorders. Thus, the COVID-19 mechanisms for stimulating cognitive dysfunction may include neuroinflammation, which is mediated by a sustained systemic inflammation, a disrupted brain barrier, and severe glial reactiveness, especially within the limbic system. This review explores the interplay of infected lungs and brain in COVID-19 and its impact on the cognitive function.


  • Oxidative stress in multiple organs after sepsis in elderly rats

    by Willian Margotti, Mariana Pereira de Souza Goldim, Richard Simon Machado, Erick Bagio, Carlos Dacoregio, Gabriela Bernades, Everton Lanzzarin, Solange Stork, Thaina Cidreira, Tais Luise Denicol, et al.


  • 6‐Shogaol improves behavior and memory in Wistar rats prenatally exposed to lipopolysaccharide

    by Naiana da Rosa, Fabiana Durante de Medeiros, Juliana de Oliveira, Ana Olívia Martins Laurentino, Eduardo de Medeiros Peretti, Richard Simon Machado, Jucélia Jeremias Fortunato, Fabrícia Petronilho

    Objective: 6‐Shogaol, bioactive compound of Zingiber officinale Roscoe, has anti‐inflammatory, antioxidant, and neuroprotective properties. The objective of the present study was to verify the effect of 6‐shogaol on behavioral parameters in a preclinical model based on a maternal immune activation (MIA) by lipopolysaccharide (LPS).Methodology: Twelve pregnant Wistar rats received 100‐μg/kg LPS or saline solution on gestational day (GD) 9.5. Male offspring participated in the study and in the postnatal day (PND) 30 and 55 were supplemented with 6‐shogaol or saline solution, by gavage at a dose of 10 mg/kg/day, orally for 5 days. In the PND 35 and 60 was performed the behavioral tests: grooming, crossing, and rearing that evaluated repetitive movements, anxiety, and interest in the new, respectively, and the inhibitory avoidance test that evaluated short‐term (STM) and long‐term memory (LTM).Result: Prenatal exposure to LPS increased the grooming and crossing episodes at different ages and reduced rearing episodes in PND 37. Treatment with 6‐shogaol reversed these parameters. In the inhibitory avoidance test, an improvement of memory was identified with 6‐shogaol in the STM and LTM at both ages comparing training and test session of treated groups and between groups.Conclusion: Administration of 6‐shogaol reverses the stereotypy, exploratory behavior, and memory impairment in prenatal LPS‐exposed offspring, acting as a promising therapeutic component against brain disorders associated with the process of MIA.


  • 6-Shogaol Exerts a Neuroprotective Factor in Offspring after Maternal Immune Activation in Rats

    by Naiana da Rosa, Fabiana Durante de Medeiros, Juliana de Oliveira, Ana Olívia Martins Laurentino, Eduardo de Medeiros Peretti, Richard Simon Machado, Millena Pais Lourenço, Thatiany Igreja da Silva, Tamires da Cunha Fernandes, Patrícia Alves Reis, et al.

    6-Shogaol is one of the main active phenolic components of ginger and has neuroprotective effects by protecting brain against the oxidative stress and regulate the levels of neurotrophic factors. The objective of the present study was to verify the effect of 6-shogaol on neurochemical parameters in offspring after maternal immune activation by lipopolysaccharide (LPS) in rats. Twelve pregnant Wistar rats received 100 μg/kg of LPS or saline solution on the gestational day 9.5. Male offspring participated in the study and from the postnatal days (PND) 30 and 55, respectively, they were supplemented with 6-shogaol or saline solution, by gavage at a dose of 10 mg/kg/day, orally for 5 days. In PND 37 and 62, analysis of kinase signaling regulated by extracellular signal 1/2 (ERK 1/2), levels of neurotrophic factor derived from the brain (BDNF), and neuron-specific enolase (NSE), lipid and protein oxidative damage was evaluated by 4-hydroxy-2-nonenal (HNE) and 3-nitrotyrosine (3-NT), respectively, and myeloperoxidase (MPO) activity was performed in the hippocampus. Prenatal exposure to LPS significantly decreased ERK and BDNF levels in PND 37 and 62, increased NSE levels and lipid damage in rats in PND 37, and increased 3-NT level in rats in PND 62. With treatment using 6-shogaol, an increase in ERK and BDNF levels was identified in PND 37 and 62 and a reduction in HNE and MPO activity in rats in PND 37 and 62, respectively. 6-Shogaol positively increased markers of neuronal growth, plasticity and synaptic activity and reduced oxidative damage in the hippocampus in an animal model of autism by maternal immune activation.